Table 1.
Case 1 | Case 2 | |||
Current Age (year) | 19 | 68 | ||
Age at Onset of GD (year) | 8 | 68 | ||
Alb | g/dL | 4.3 | 4.1 | |
Ca | mg/dL | 6.7 | 6.9 | |
P | mg/dL | 4.8 | 3.5 | |
Mg | mg/dL | 1.5 | 1.5 | |
ALP | IU/L | 803 | 360 | |
Cr | mg/dL | 0.4 | 0.51 | |
Intact-PTH | pg/mL (10-65) | 34 | 7.0 | |
TSH | uU/mL (0.35-4.94) | <0.001 | 58.3, | <0.03* |
FT3 | pg/mL (1.71-3.71) | 5.85 | 1.04 | |
FT4 | ng/dL (0.70-1.48) | 1.29 | <0.40, | 3.09* |
TRAb-2 | IU/L (<1.0) | N/A | 1.7** | |
TRAb-3 | IU/L (<2.0) | 2,080 | N/A | |
TSAb | % (<120) | 1,072 | 164** | |
TgAb | IU/mL (<28.0) | 8 | 30.2 | |
TPOAb | IU/mL (<16.0) | 10.2 | 581.5 |
Note: underline denotes abnormal values. TSAb: thyroid stimulating antibody TRAb: anti-thyroid-stimulating hormone receptor antibody, TRAb-2: TRAb-second generation assay, TRAb-3: TRAb-third generation assay, TgAb: anti-thyroglobulin antibody, TPOAb: anti-thyroid peroxidase antibody
N/A: not applicable *data measured at onset of GD in another hospital. **measured in euthyroid during L-T4 treatment.